Hamm John M. 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Apr 29, 2022
Insider Transaction Report
Form 4
Hamm John M.
Chief Financial Officer
Transactions
- Award
Options (right to buy)
2022-03-16+2,000→ 2,000 totalExercise: $2.59From: 2026-03-16Exp: 2032-03-16→ Common Stock (2,000 underlying) - Award
Common Stock
2022-03-16$2.59/sh+20,000$51,800→ 26,800 total
Footnotes (2)
- [F1]100% vesting on March 16, 2025.
- [F2]100% vesting on March 16, 2026.